4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-063101
SVP, Diagnostics, clonoSEQ sold 25,000 shares at $55.00 ($1,375,000)
- SVP, Diagnostics, clonoSEQ acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 2020-12-10 | Option exercise | +25,000 | $1.98 | $49,500 | 25,000 | D |
| BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 2020-12-10 | Sale | −25,000 | $55.00 | $1,375,000 | 0 | D |
| Derivatives | |||||||
| BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 2020-12-10 | Option exercise · Stock Option (Right to Buy) | −25,000 | 30,000 | D | ||
| Open-market sales · 25,000 sh · avg $55.00 · $1,375,000 | |||||||
Loading xslF345X03/doc4.xml…